FDA Clearance Tracker · K200482
StimRouter Neuromodulation System
Last checked: Nov 19, 2026Latest source record: Mar 27, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Mar 27, 2020
Substantially Equivalent
Time to decision
29 days
Received Feb 27, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K200482
- Device name
- StimRouter Neuromodulation System
- Applicant
- Bioness, Inc.
- Applicant location
- Valencia, CA
- Received
- Feb 27, 2020
- Decided
- Mar 27, 2020
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5870
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GZF. The earliest in FDA's data is K904409, decided Jan 30, 1991.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K200482
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Bioness, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K211965 · Decided Feb 23, 2022 · 244 days after receipt
Device type: Stimulator, Peripheral Nerve, Implanted (Pain Relief) (GZF) · Neurology & Neurosurgery
- L100 Go System510(k)
K200262 · Decided Mar 4, 2020 · 30 days after receipt
Device type: Stimulator, Neuromuscular, External Functional (GZI) · Neurology & Neurosurgery
K190047 · Decided Oct 31, 2019 · 295 days after receipt
Device type: Stimulator, Peripheral Nerve, Implanted (Pain Relief) (GZF) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.